Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. (Record no. 19912871)

MARC details
000 -LEADER
fixed length control field 01657 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515230320.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201010s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/cncr.25320
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hainsworth, John D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20101012
245 00 - TITLE STATEMENT
Title Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Sep 2010
300 ## - PHYSICAL DESCRIPTION
Extent 4122-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Everolimus
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sirolimus
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Infante, Jeffrey R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spigel, David R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peyton, James D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thompson, Dana S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lane, Cassie M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clark, Bobby L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rubin, Mark S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trent, David F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burris, Howard A
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 116
-- no. 17
-- p. 4122-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/cncr.25320">https://doi.org/10.1002/cncr.25320</a>
Public note Available from publisher's website

No items available.